AACR Oncology Industry Partnering Event: From Cancer Discoveries to Patients
April 24-25, 2025
McCormick Convention Center West
Chicago, Illinois
Cochairs
Michael A. Caligiuri, City of Hope National Medical Center, Duarte, California
Christiana Bardon, MPM | BioImpact Capital, Boston, Massachusetts
William N. Hait, Johnson & Johnson (ret.), New Brunswick, New Jersey
The AACR is excited to present the Second AACR Oncology Industry Partnering Event: From Cancer Discoveries to Patients on April 24-25, 2025, in Chicago, immediately prior to the AACR Annual Meeting 2025. Following the success of the inaugural program in San Diego that attracted over 400 attendees, the 2025 program has been expanded to accommodate up to 1,000 attendees and features podium presentations from both major pharmaceutical companies and small-mid size biotechnology companies. This oncology-focused event is once again attracting researchers and industry partners to share innovation strategies for drug development and presenting analysts and investors with new partnership and licensing opportunities to advance these concepts.
The AACR is known for facilitating innovation through translational science – turning clinical observations and early scientific discoveries into actionable insights and patient interventions more efficiently. Hosting the AACR Oncology Industry Partnering Event is an important example of how the AACR convenes academic clinicians, big pharma, biotech, business development, venture capital, and investment banking to accelerate progress with cancer treatments and cures that directly benefit patients globally.
platinum supporter
silver supporters
City of Hope
Decheng Capital
MPM BioImpact
Royalty Pharma
Zymeworks